Meet Taiwo Adesoye, M.D.
Taiwo Adesoye, MD, MPH
Department of Breast Surgical Oncology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2015 | Harvard T.H. Chan School of Public Health, Boston, Massachusetts, US, Public Health, Clinical Effectiveness, MPH |
| 2012 | University of Chicago, Pritzker School of Medicine, Chicago, Illinois, US, Doctor of Medicine, MD |
| 2007 | University of Oklahoma, Norman, Oklahoma, US, Bachelor of Science, Biochemistry, BA |
Postgraduate Training
| 2020-2021 | Fellowship, Breast Surgical Oncology, MD Anderson Cancer Center, Houston, Texas |
| 2017-2020 | General Surgery Resident, Houston Methodist Hospital, Houston, Texas |
| 2016-2017 | Research Fellowship, T32 surgical Oncology Research Fellow, MD Anderson Cancer Center, Houston, Texas |
| 2014-2016 | Research Fellowship, T32 surgical Oncology Research Fellow, University of Wisconsin Hospital and Clinics, Madison, Wisconsin |
| 2013-2016 | General Surgery Resident, University of Wisconsin Hospital and Clinics, Madison, Wisconsin |
| 2012-2013 | General Surgery Intern, University of Wisconsin Hospital and Clinics, Madison, Wisconsin |
Licenses & Certifications
| 2020 | American Board of Surgery |
| 2020 | Drug Enforcement Agency |
| 2020 | Texas Medical Board |
| 2012 | NPI |
| 2012 | Advanced Trauma Life Support |
Experience & Service
Administrative Appointments/Responsibilities
Member, Academic Policy Council, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Research Program/Community Outreach and Engagement (RP/COE) Liason, Experimental Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
CAO Task Force: Evaluating and enhancing the faculty mid-cycle review process, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Project lead, Rapid Access Clinic development, Readmissions reduction initiative, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Co-Director, Surgical Oncology Clinical Trial Course, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Member, Advisory Council for Clinical Research Leaders, Academic Affairs, Sr VP Office, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Project Lead, Post-Discharge Appointment Coordination, Hospital Throughput Initiative, Office of Chief Operating Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - Present
Co-Chair, BSO Journal Club, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - Present
Program Director, Observer Program, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Assistant director, Surgical Oncology Clinical Trial Course, Surgical Oncology Clinical Trial Course - Fellows, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - 2024
Representative, Faculty Senate, Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - 2025
Other Professional Positions
Society of Surgical Oncology Disease Site Working group, Society of Surgical Oncology, 2024 - Present
Member, Alliance Prevention Committee, Chicago, IL, 2021 - Present
Member, Alliance Breast Committee, Chicago, IL, 2021 - Present
Member, American Society of Breast Surgeons Fellows Working Group, San Antonio, TX, 2021 - 2024
Member, American College of Surgeons Cancer Research Program Dissemination & Implementation committee, Chicago, IL, 2021 - 2023
Member, American College of Surgeons Cancer Research Program Education committee, Chicago, IL, 2021 - 2023
Graduate Medical Education Office House Staff Council, Houston Methodist Hospital, Houston, 2019 - 2020
General Surgery Program Representative, Houston Methodist Hospital, Houston, TX, 2019 - 2020
Intramural Institutional Committee Activities
Member, CAO Mid-Cycle Review Task Force, The University of Texas MD Anderson Cancer Center, 2026 - Present
Extramural Institutional Committee Activities
Alternate Member, Research Policy Advisory Council, The University of Texas MD Anderson Cancer Center, 2025 - Present
Alternate Member, Academic Policy Council (APC), The University of Texas MD Anderson Cancer Center, 2025 - Present
Advisor, Advisory Council for Clinical Research Leaders, MD Anderson Cancer Center, 2024 - Present
Member, Academic Review Committee for the Division of Education & Training, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Group Leader, Surgical Oncology Clinical Trial Course - Fellows, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Member, Academic Review Committee for the Division of Education & Training, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Group Leader, Surgical Oncology Clinical Trial Course - Fellows, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Member, Department of Surgery Diversity Equity and Inclusion Committee, The University of Texas MD Anderson Cancer Center, 2022 - 2023
Member, Academic Review Committee for the Division of Education & Training, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Reviewer, Breast Surgical Oncology Fellowship Clinical Competency Review Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
House Staff Senate, Diversity and Disparities Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
House Staff Senate, Global Oncology Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
House Staff Senate, Wellness and Career Sustainability Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Breast Surgical Oncology Representative, House Staff Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Dean's Advisory Committee on Diversity and Inclusion, Harvard TH Chan School of Public, 2014 - 2015
Voting member, Admissions Committee, University of Chicago, 2011 - 2012
Editorial Activities
Editorial board member, Journal of surgical oncology, 2025 - Present
Honors & Awards
| 2020 | Graduate Medical Education Teaching and Leadership Award, Houston Methodist Hospital |
| 2019 | Resident Leadership Award, Houston Methodist Hospital |
| 2013 | Junior Resident ABSITE Award, University of Wisconsin School of Medicine and Public Health |
| 2013 | General Surgery Clerkship Teaching Award, University of Wisconsin School of Medicine and Public Health |
| 2008 - 2012 | Pritzker Grant, University of Chicago, Pritzker School of Medicine |
| 2007 | Phi Beta Kappa, University of Oklahoma |
| 2006 | Corinne Price Scholarship, University of Oklahoma |
| 2003 - 2007 | President’s Honor Roll, University of Oklahoma |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Updates in Breast Cancer Care: Implications for Rehabilitation, Palliative and Integrative Oncology. Invited. Rehabilitation Grand rounds. Houston, Texas, US.
- 2026. So You Want to Become a Surgeon. Invited. UT MD Anderson UT Health graduate school’s Graduate Education Committee. Houston, Texas, US.
- 2024. ASCO Advantage is a disease-state content, interactive, educational program. Invited. ASCO Advantage. Houston, Texas, US.
- 2024. Advancements in Treatment Strategies for HER2 Positive Breast Cancer. Invited. National Black Breast Cancer Summit. Houston, Texas, US.
- 2024. Breast Surgical Oncology Department MD Anderson Cancer Center. Invited. Big Brothers Big Sisters College & Career Readiness Teen Conference. Houston, Texas, US.
- 2024. A Breast Health Series. Invited. Take Care of You Sis Brunch and Learn. Houston, Texas, US.
- 2024. Updates in Surgical Approach - Best Breast Practice. Invited. BTF Best of ASH and SABCS. Houston, Texas, US.
- 2022. San Antonio Breast Cancer Conference 2021 updates. Conference. Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center. Houston, TX, US.
Regional Presentations
- 2026. Highlights from San Antonio Breast Cancer Symposium 2025. Invited. Breast Clinical and Translational Research (BCCTR) Conference. Houston, Texas, US.
- 2025. Advanced Breast Cancer Conference: Local Management and Other New Perspectives. Invited. Advanced Breast Cancer Conference. Houston, Texas, US.
National Presentations
- 2026. The Evolving Role of Sentinel Lymph Node Biopsy in Upfront Surgery for Breast Cancer. Invited. Vumedi.
- 2026. SABCS Review: Local Therapy of Breast Cancer. Invited. Colorado Oncology Society 2026 Official SABCS Review and GI Update. Denver, Colorado, US.
- 2025. Breast SSO2025 Recap. Panelist. Society of Surgical Oncology, US.
- 2025. Breast Cancer Prevention. Invited, US.
- 2025. SSO2025 updates in breast cancer research. Panelist, US.
- 2025. Primary Tumor Surgery For De Novo Stage IV Breast Cancer. Invited. VVP collective, US.
- 2025. oPrimary Tumor Surgery For De Novo Stage IV Breast Cancer. Invited. VVP collection. Virtual, Texas, US.
- 2024. Hot Topics in Breast Cancer. Invited. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2024. Clinical Implementation of the Sound Trial. Invited. SSO Annual Conference. Houston, TX, US.
- 2024. Screening and Diagnosis. Invited. ASCO Advantage: Breast Cancer. Orlando, FL, US.
- 2024. Bringing it All Together (Tumor Board). Panelist. ASCO Advantage: Breast Cancer. Orlando, FL, US.
- 2024. Clinical Case Breakouts: Metastatic HER2+. Panelist. ASCO Advantage: Breast Cancer. Orlando, FL, US.
- 2024. Clinical Case Breakouts: Early Stage HR+. Panelist. ASCO Advantage: Breast Cancer. Orlando, FL, US.
- 2024. Management of cT1-2 N0 TNBC. Invited. American College of Surgeons TNBC. San Diego, CA, US.
- 2024. Breast Cancer Workshop: Targeted Oncology Clinical Congress Consultants. Conference. Breast Cancer Workshop: Targeted Oncology Clinical Congress Consultants. Chicago, IL, US.
- 2023. Evaluating the role of CDK4/6 inhibition on STAT3 activation in a transgenic mouse model of HER2-positive breast cancer. Conference. Evaluating the role of CDK4/6 inhibition on STAT3 activation in a transgenic mouse model of HER2-positive breast cancer. San Antonio, TX, US.
- 2022. San Antonio Breast Cancer Conference 2021 updates. Conference. San Antonio Breast Cancer Conference 2021 updates. Houston, TX, US.
- 2018. Training-the-Trainer: Evaluation of an Intraoperative Teaching Intervention for Surgeon Educators. Conference. Training-the-Trainer: Evaluation of an Intraoperative Teaching Intervention for Surgeon Educators. Boston, MA, US.
- 2017. Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer. Conference. Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer. Seattle, WA, US.
- 2016. Utilization of Breast Imaging after Treatment for Locoregional Breast Cancer. Conference. Utilization of Breast Imaging after Treatment for Locoregional Breast Cancer. Washington, DC, US.
- 2016. Current management of Phyllodes Tumors of the Breast. Conference. Current management of Phyllodes Tumors of the Breast. Dallas, TX, US.
- 2015. Geographic Variation in Medicare and Military Healthcare Systems. Conference. Geographic Variation in Medicare and Military Healthcare Systems. Minneapolis, MN, US.
- 2014. Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas. Conference. Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas. Phoenix, AZ, US.
- 2011. The role of an Objective Standardized Clinical Evaluation (OSCE) in evaluation of student performance in the Neurology Clerkship. Conference. The role of an Objective Standardized Clinical Evaluation (OSCE) in evaluation of student performance in the Neurology Clerkship. Honolulu, HI, US.
- 2009. Statins for the early treatment of sepsis (SETS) – A pilot study. Conference. Statins for the early treatment of sepsis (SETS) – A pilot study. Chicago, IL, US.
International Presentations
- 2025. Research biopsy participation and safety in cancer therapeutic trials. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. Boston, US.
- 2025. Optimal Management of DCIS/ Surgical Management vs. Active Surveillance in DCIS. Invited. Mexican Association of Mastology 22th National Congress, and 11th Virtual Congress. Oaxaca, MX.
- 2025. Surgical management in patients with breast cancer carrying pathogenic mutations and the role of risk-reducing contralateral mastectomy ?. Invited. Mexican Association of Mastology 22th National Congress, and 11th Virtual Congress. Oaxaca, MX.
- 2025. Early clinical stage luminal breast cancer. Selecting the best treatment. Initial surgical treatment. Invited. Mexican Association of Mastology 22th National Congress, and 11th Virtual Congress. Oaxaca, MX.
- 2025. Triple-Negative Breast Cancer - Breast Cancer in Young Patients. Invited. Brazilian Breast Cancer Society - Southern Brazil, BR.
- 2024. Bridging the Cancer Care Gap: Fostering Collaborations and Cancer Capacity Building. Conference. Global Oncology Program at MD Anderson Cancer Center, the Zambia Ministry of Health, and the Cancer Diseases Hospital in Zambia. Lusaka, ZM.
Formal Peers
- 2024. SOUND, SENOMAC and AMAROS trials. Houston, Texas, US.
- 2024. Multidisciplinary approaches to SLN and ALND omission based on the SOUND, SENOMAC, and AMAROS trials. Houston, Texas, US.
- 2024. Translational Research & Incorporation into Trial Design. Houston, Texas, US.
- 2024. Advancements in Treatment Strategies for HER2-Positive Breast Cancer. Houston, Texas, US.
- 2024. SOUND, SENOMAC and AMAROS trials. Houston, Texas, US.
- 2024. Breast Surgery: Targeted Axillary Dissection Indications and technique. Conference, US.
- 2024. Complex General Surgical Oncology Lecture Series: Triple Negative Breast Cancer. Houston, TX, US.
- 2024. MultiD Management of TNBC. Visiting. Houston, TX, US.
- 2024. Best of Breast SABCS and AACR. Houston, TX, US.
- 2024. Surgery in Stage 4 breast cancer. Conference, US.
- 2023. Triple Negative Breast Cancer. Houston, TX, US.
- 2022. Triple Negative Breast Cancer. Visiting. Houston, TX, US.
Grant & Contract Support
| Date: | 2024 - Present |
| Title: | Robert A. Winn Excellence in Clinical Trials Award Program |
| Funding Source: | Bristol Myers Squibb Foundation |
| Role: | PI |
| Date: | 2022 - 2024 |
| Title: | Paul Calabresi Clinical Oncology Award |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | PAR19-242 K12 K12CA088084-21 |
Selected Publications
Peer-Reviewed Articles
- Valero¹ V, Pohlmann¹ PR, Mouabbi¹ J, Huang² X, Qiao² W, HeatherAlonzo¹, Murthy¹ RK, Rauch³ GM, Adesoye T, Checka⁴ C, WSymmans⁵ F, Grachev⁶ D, Alajajyan⁶ F, Nwosu-Iheme A, Hassan A, Patel M, Giordano¹ SH, Hunt⁴ K, Tripathy¹ D, Meric-Bernstam⁴ F. A Phase 2 Single-Arm Open-Label Trial Evaluating Zanidatamab in Patients with Early Stage HER2-positive Breast Cancer: The NeoZanHER Study. Nature Communications. e-Pub 2026.
- Chen JH, Wanis KN, Rahman M, Gianchandani A, Bedrosian I, Tamirisa N, Yi M, Raghavendra A, Singh P, Teshome M, Sun S, Kuerer H, Hunt KK, Meric-Bernstam F, Adesoye T. ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy. Ann Surg Oncol, 2026. e-Pub 2026.
- Adesoye T, Michelle E, Le H, Hong D, Chi X, Belay SY, Liu JY, Rodon J, Dumbrava EE, Naing A, Piha-Paul SA, Fu S, Tang T, Tsimberidou AM, Tam AL, Murthy R, McNeill LH, Meric-Bernstam F. Research Biopsy Participation and Safety in Early Phase Clinical Trials. CCR. e-Pub 2026.
- Chen JH, Wanis KN, Rahman M, Gianchandani A, Bedrosian I, Tamirisa N, Yi M, Raghavendra A, Singh P, Teshome M, Sun S, Kuerer H, Hunt KK, Meric-Bernstam F, Adesoye T. Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy. Ann Surg Oncol, 2026. e-Pub 2026. PMID: 41949735.
- Torrado C, Andersen CR, Kang L, Brink AL, Adesoye T, Le H, Patterson CJ, Poullard A, Osburn JA, Tan HN, Gouda MA, Charles S, Urschel GE, Tang T, Hong DS, Champiat S, Naing A, Tsimberidou AM, Dumbrava EE, Piha-Paul SA, Rodon J, Yap TA, Pohlmann PR, Meric-Bernstam F, Fu S. Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity. Oncologist, 2026. e-Pub 2026. PMID: 41830429.
- Cata, JP, Owusu-Agyemang, P, Adesoye, T, Feng, L. Association between race, ethnicity, and surgical case cancellations. Journal of Clinical Anesthesia 106, 2025. e-Pub 2025. PMID: 40627996.
- Wanis, K, Mitchell, MP, Giordano, SH, Litton, J, Shaitelman, SF, Tamirisa, N, Bedrosian, I, Dong, W, Shen, Y, Hunt, KK, Singh, P, Sun, SX, Caudle, AS, Kuerer, HM, Meric-Bernstam, F, Hwang, RF, Adesoye, T. Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers. Cancer 131(11), 2025. e-Pub 2025. PMID: 40433858.
- Wanis KN, Dong W, Shen Y, Meric-Bernstam F, Adesoye T, Kuerer HM, Caudle AS, Tamirisa N, DeSnyder SM, Sun SX, Bedrosian I, Singh P, Cox SE, Hunt KK, Hwang RF. Predicting pathologic ≥N2 disease in women with breast cancer. Nature 11(1), 2025. e-Pub 2025. PMID: 40404657.
- Muppidi, N, Adesoye, T, Yi, M, Sun, SX, Chavez-MacGregor, M, Singh, P, Karuturi, MS, Tamirisa, N, Hunt, KK, Teshome, M. Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Annals of surgical oncology 31(13):8795-8801, 2024. e-Pub 2024. PMID: 39192013.
- Muppidi, N, Adesoye, T, Hunt, KK, Teshome, M. ASO Author Reflections-Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer. Annals of surgical oncology 31(13):8908-8909, 2024. e-Pub 2024. PMID: 39251515.
- Glencer, AC, Wanis, KN, Brown, S, Lucci, A, Sun, SX, Adesoye, T, DeSnyder, SM, Layman, RM, Woodward, W, Hunt, KK, Teshome, M. Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership. Annals of surgical oncology 31(11):7326-7334, 2024. e-Pub 2024. PMID: 39034365.
- Everidge, S, Sun, J, Teshome, M, Tamirisa, N, Sun, SX, Adesoye, T, Nia, ES, Bevers, TB, Bedrosian, I, Patel, MM, Singh, P. ASO Visual Abstract. Annals of surgical oncology 31(4):2276-2277, 2024. e-Pub 2024. PMID: 38263369.
- Everidge SA, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Nia E, Bevers T, Bedrosian I, Patel M, Singh P. Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management. Ann Surg Oncol 31(4):2224-2230, 2024. e-Pub 2024. PMID: 38117388.
- Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg 238(1):1-9, 2024. e-Pub 2024. PMID: 37870227.
- Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, Woodward WA, Lucci A. ASO Visual Abstract: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol 30(10):6241-6242, 2023. e-Pub 2023. PMID: 37578608.
- Adesoye T, Everidge S, Chen J, Sun SX, Teshome M, Valero V, Woodward WA, Lucci A. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol 30(10):6232-6240, 2023. e-Pub 2023. PMID: 37479842.
- Adesoye T, Lucci A. ASO Author Reflections: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy. Ann Surg Oncol 30(10):6243-6244, 2023. e-Pub 2023. PMID: 37610486.
- AdesoyeT, Liao KP, Peterson S, Li L, Zorzi D, Holmes HM, Chavez-MacGregor M, Giordano SH. Patient-reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment. Cancer Med 12(17):17740-17752, 2023. e-Pub 2023. PMID: 37551136.
- Hassan AM, Ketheeswaran S, AdesoyeT, Shah SA, Cox SE, Kapur SK, Checka CM, Offodile AC. Association between patient-surgeon race and gender concordance and patient-reported outcomes following breast cancer surgery. Breast Cancer Res Treat 198(1):167-175, 2023. e-Pub 2023. PMID: 36622543.
- Farley, CR, Irwin, S, Adesoye, T, Sun, SX, DeSnyder, SM, Lucci, A, Shaitelman, SF, Chang, EI, Ueno, NT, Woodward, W, Teshome, M. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment. Annals of surgical oncology 29(10):6370-6378, 2022. e-Pub 2022. PMID: 35854031.
- Cobb AN, Diao K, AdesoyeT, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
- Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol 28(13):8610-8621, 2021. e-Pub 2021. PMID: 34125346.
- Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome M. Inflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol 28(10):5626-5634, 2021. e-Pub 2021. PMID: 34292426.
- Adesoye T, Davis CH, Del Calvo H, Shaikh AF, Chegireddy V, Chan EY, Martinez S, Pei KY, Zheng F, Tariq N. Optimization of Surgical Resident Safety and Education During the COVID-19 Pandemic – Lessons Learned. J Surg Educ, 2021. e-Pub 2021.
- Adesoye T, Davis CH, Del Calvo H, Shaikh AF, Chegireddy V, Chan EY, Martinez S, Pei KY, Zheng F, Tariq N. "Optimization of Surgical Resident Safety and Education During the COVID-19 Pandemic - Lessons Learned". J Surg Educ 78(1):315-320, 2021. e-Pub 2021. PMID: 32739443.
- Choo EK, Girgis C, Han CS, Simard JF, Adesoye T, Linos E, Mangurian C, Study Group PMG. High Prevalence of Peripartum Depression Among Physician Mothers: A Cross-Sectional Study. Am J Psychiatry 176(9):763-764, 2019. e-Pub 2019. PMID: 31474130.
- Schumacher JR, Neuman HB, Chang GJ, Kozower BD, Edge SB, Yu M, Vanness DJ, Si Y, Jacobs EA, Francescatti AB, Spears PA, Havlena J, Adesoye T, McKellar D, Winchester D, Burnside ES, Greenberg CC, Working Group AACBCS. A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01). Ann Surg Oncol 25(9):2587-2595, 2018. e-Pub 2018. PMID: 29777402.
- Adesoye T, Schumacher JR, Neuman HB, Edge S, McKellar D, Winchester DP, Francescatti AB, Greenberg CC, Working Group AACBCS. Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01). Ann Surg Oncol 25(6):1502-1511, 2018. e-Pub 2018. PMID: 29450753.
- Neuman HB, Schumacher JR, Francescatti AB, Adesoye T, Edge SB, Vanness DJ, Yu M, McKellar D, Winchester DP, Greenberg CC, Working Group ACOSCRPCCDRBCS. Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer (AFT-01). J Clin Oncol 36(10):975-980, 2018. e-Pub 2018. PMID: 29384721.
- Adesoye T, Kimsey LG, Lipsitz SR, Nguyen LL, Goodney P, Olaiya S, Weissman JS. Geographic variation in Medicare and the military healthcare system. Am J Manag Care 23(8):e259-e264, 2017. e-Pub 2017. PMID: 29087149.
- Adesoye T, Adesoye T, Mangurian C, Mangurian C, Choo EK, Choo EK, Girgis C, Girgis C, Sabry-Elnaggar H, Sabry-Elnaggar H, Linos E, Linos E. Perceived Discrimination Experienced by Physician Mothers and Desired Workplace Changes-A Cross-sectional Survey. JAMA Intern Med, 2017. e-Pub 2017. PMID: 28492824.
- Neuman HB, Schumacher JR, Francescatti AB, Adesoye T, Edge SB, Burnside ES, Vanness DJ, Yu M, Si Y, McKellar D, Winchester DP, Greenberg CC. Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer. Ann Surg Oncol 23(10):3385-91, 2016. e-Pub 2016. PMID: 27491784.
- Taylor LJ, Adesoye T, Maloney JD. Video-assisted thoracic surgery for cancer after thoracic aortic aneurysm repair. Asian Cardiovasc Thorac Ann 24(2):201-3, 2016. e-Pub 2016. PMID: 26430132.
- Adesoye T, Daleo MA, Loeffler AG, Winslow ER, Weber SM, Cho CS. Discordance of Histologic Grade Between Primary and Metastatic Neuroendocrine Carcinomas. Ann Surg Oncol 22 Suppl 3:S817-21, 2015. e-Pub 2015. PMID: 26193965.
- Lukas RV, Adesoye T, Smith S, Blood A, Brorson JR. The Role of an Objective Standardized Clinical Evaluation (OSCE) in evaluation of student performance in the Neurology Clerkship. Neurology, 2011. e-Pub 2011. PMID: 22855865.
Invited Articles
- Adesoye T, Debasish T, Kelly H, Khandan K. Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics. Cancers (Basel), 2024. e-Pub 2024. PMID: 38339245.
Review Articles
- Adesoye T, Dumbrava EE, Kanwal R, Sahin A, Chen H, Lee S, Javle M, Pant S, Alhalabi O, Le X, Valero V, Pohlmann PR, Meric-Bernstam F. Advances in Targeting HER2 across Cancer Subtypes – A Pan-tumor Approach. Clinical Cancer Research, 2026. e-Pub 2026. PMID: 41283902.
- Johnson, N, Bea, V, Adesoye, T, Newman, LA. Increasing the Diversity of Patients Contributing to Breast Cancer Biobanks. Current Breast Cancer Reports 17(1), 2025. e-Pub 2025.
- Bhala, R, Cando, LF, Verma, P, Adesoye, T, Bhardwaj, A. Biomarkers Predicting Progression and Prognosis of Ductal Carcinoma In Situ (DCIS). Anticancer research 45(4):1305-1328, 2025. e-Pub 2025. PMID: 40155037.
- Adesoye T, Lucci A. Current Surgical Management of Inflammatory Breast Cancer. Ann Surg Oncol 28(10):5461-5467, 2021. e-Pub 2021. PMID: 34346020.
- Adesoye T, Neuman HB, Wilke LG, Schumacher JR, Steiman J, Greenberg CC. Current Trends in the Management of Phyllodes Tumors of the Breast. Ann Surg Oncol 23(10):3199-205, 2016. e-Pub 2016. PMID: 27334214.
- Adesoye T, Greenberg CC, Neuman HB. Optimizing Cancer Care Delivery through Implementation Science. Front Oncol 6:1, 2016. e-Pub 2016. PMID: 26858933.
- Fernandes-Taylor S, Adesoye T, Bloom JR. Managing psychosocial issues faced by young women with breast cancer at the time of diagnosis and during active treatment. Curr Opin Support Palliat Care 9(3):279-84, 2015. e-Pub 2015. PMID: 26164840.
Other Articles
- Cobb, AN, Adesoye, T, Teshome, M Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer. Annals of surgical oncology 29(5):2756-2758, 2022. PMID: 35152360.
Editorials
- Schlam I, Adesoye T, Lee AV, AndreaRichardson, Lin NU, Winer EP, Krop IE, Wolff AC, Spears PA, Koegel SL, Nanda R, Gupta G, DeMichele A, Rimm D, Medford A, Rozenblit M, Hunter N, Symmans W, Balko J, Park BH, Parsons HA, Working Group OBOTTCS. From promise to practice: Evidence and unanswered questions in MRD testing for early breast cancer. JCO.
- Koegel SL, Spears PA, Park BH, Lee AV, Richardson A, ULin N, Winer EP, Krop IE, Wolff AC, Parsons HA, Schlam I, Adesoye T, Science MPH, Working Groups PA. Circulating tumor DNA testing in early-stage breast cancer: A patient perspective on emerging uses. JCO.
- Kantor O, Al-Hilli Z, Group SSO. Surgical Perspective on the Updated American College of Radiology Supplemental Screening Guidelines for Breast Density. Ann Surg Onc, 2026. PMID: 42036599.
- Olga Kantor MD, MS, Ashley A Woodfin MD, Michelle Specht MD, Working Group SOSOBDS. Breast Surgical Perspectives on the NSABP B-51/RTOG 1304 Trial on Omission of Regional Nodal Irradiation After Response to Neoadjuvant Chemotherapy. Ann of Surg Oncol, 2026. PMID: 41555134.
- Showalter, SL, Laronga, C, Woodfin, AA, Weiss, A, Tranakas, N, Park, KU, Neblock-Beirne, T, Montagna, G, Kumar, S, Kesmodel, SB, Kantor, O, Hwang, ES, Grumley, J, Fayaniu, O, Dominici, LS, Botty Van den Bruele, A, Anderson, D, Al-Hilli, Z, Agnese, DM, Adesoye, T, Dirbas, FM, Boughey, JC. Highlights and Perspectives from the Society of Surgical Oncology’s Statements on Bilateral and Contralateral Risk-Reducing Mastectomy. Annals of surgical oncology 32(6):3857-3860, 2025. PMID: 40210811.
- Mitchell M, Adesoye T, Shaitelman S, Barcenas C, Hwang R. Lymph Node Management of Patients With Breast Cancer in the Era of Therapy De-escalation. Pract Radiat Oncol, 2025. PMID: 41758096.
- Adesoye T, Katz MHG, Offodile AC. Meeting Trial Participants Where They Are: Decentralized Clinical Trials as a Patient-Centered Paradigm for Enhancing Accrual and Diversity in Surgical and Multidisciplinary Trials in Oncology. JCO Oncol Pract, 2023. PMID: 36821820.
- Adesoye T, Sun SX, Schaverien MV, Woodward WA, Lucci A. Immediate Breast Reconstruction in Inflammatory Breast Cancer - Are We There Yet?. Ann Surg Oncol, 2022. PMID: 35471749.
- Adesoye T, Irwin S, Sun SX, Lucci A, Teshome M. Contemporary surgical management of inflammatory breast cancer: a narrative review. Chin Clin Oncol 10(6):57, 2021. PMID: 35016511.
Abstracts
- Everidge S, Sun J, Teshome M, Tamirisa N, Sun S, Adesoye T, Kapoor M, Nia E, Bevers T, Bedrosian I, Patel M, Singh P. Management of lobular neoplasia diagnosed via MRI-guided biopsy. ASBRS.
- Adesoye T, Everidge S, Chen J, Sun S, Teshome M, Valero V, Woodward WA, Lucci A. Low Rates of Local-regional Recurrence in Inflammatory Breast Cancer Patients after Contemporary Trimodality Therapy. ASBRS.
- Adesoye T, Keyomarsi K. Evaluating the Role of CDK4/6 Inhibition on STAT3 Activation in a Transgenic Mouse Model of HER2-positive Breast Cancer. SABCS.
- Chen J, Adesoye T. Implications for sentinel lymph node biopsy (SLNB) omission in patients with early-stage node-negative HR+/HER2- breast cancer undergoing mastectomy. ASCO.
- Chen J, Adesoye T. Upgrade Rates and Long-Term Outcomes Among Patients with Intraductal Papillomas: A Single-Institution Experience. ASBRS.
- Adesoye T. Research biopsy participation and safety in cancer therapeutic trials. Research biopsy participation and safety in cancer therapeutic trials.
Book Chapters
- Adesoye, T, Rosso, KJ, Klimberg, VS, Hunt, KK. General Principles of Mastectomy, 368,388.e1-388,388.e4, 2023.
- Adesoye, T, Caudle, AS. Lymphatic Mapping and Targeted Axillary Dissection Procedure After Neoadjuvant Chemotherapy, 434,438.e1-438,438.e3, 2023.
- AdesoyeT, Caudle AS. Lymphatic mapping and Targeted Axillary Dissection Procedure after Neoadjuvant Chemotherapy. In: The Breast 6e.
- Adesoye T, Hunk KK. General Principles of Mastectomy: From Halsted Radical Mastectomy, MRM, to Simple Mastectomy. In: The Breast 6e.
Patient Reviews
CV information above last modified August 17, 2026